NEW YORK, June 19 /PRNewswire/ -- WallSt.net's 3-Minute Press Show is a daily video program hosted by WallSt.net reporter, Tracee Tolentino.
Shows air Monday through Friday on: http://tv.wallst.net.
WallSt.net's 3-Minute Press Show features in-depth interviews with public company executives on their company and most recent press releases. The show is designed to provide viewers with insight into a company's most recent press release, and its impact on the company's growth.
The following executives were interviewed on today's show:
Chaim Levinson, Director of Investor Relations for BrainStorm Cell Therapeutics, Inc. (OTC Bulletin Board: BCLI) (http://www.brainstorm-cell.com). To view this clip in its entirety, visit:
Elsa Sung, Chief Financial Officer of Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GTEC) (http://www.genesis-china.net/). To view this clip in its entirety, visit:
Jeffrey Ross, Director of Finance for Newport Digital Technologies,
Inc., a wholly-owned subsidiary of International Food Products Group, Inc.
(OTC Bulletin Board: IFDG) (http://www.newportdt.com/). To view this clip
in its entirety, visit:
About WallStreet Direct, Inc.
WallStreet Direct, Inc. a wholly-owned subsidiary of Financial Media Group, Inc. (OTC Bulletin Board: FNGP - News), owns and operates WallSt.net (http://www.wallst.net), a leading source of up-to-the-minute business news, comprehensive financial tools and original multimedia content for the investment community. In addition to WallSt.net, WallStreet Direct owns and operates WallStRadio (http://radio.wallst.net) an online hub for business podcasts from well-known business news personalities and publishers, and WallStTV (http://tv.wallst.net), a hub for business and finance video content. We have received four million restricted shares of IFDG from International Food Products Group, Inc. for media and advertising services. We have received two hundred eighty dollars from BrainStorm Cell Therapeutics, Inc. for press release dissemination services provided in 2007. To read our full disclaimer, and for a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.php.
|SOURCE WallStreet Direct, Inc.; Opexa Therapeutics, Inc.;BrainStorm Cell|
Copyright©2008 PR Newswire.
All rights reserved